Skip to main navigation Skip to search Skip to main content

Erratum: A novel aminotetralin-type serotonin (5-HT)2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses (Journal of Pharmacology and Experimental Therapeutics (2014) 349 (310-318) DOI:10.1124/jpet.113.212373)

  • C. E. Canal
  • , D. Morgan
  • , D. Felsing
  • , K. Kondabolu
  • , N. E. Rowland
  • , K. L. Robertson
  • , R. Sakhuja
  • , R. G. Booth

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: A novel aminotetralin-type serotonin (5-HT)2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses (Journal of Pharmacology and Experimental Therapeutics (2014) 349 (310-318) DOI:10.1124/jpet.113.212373)'. Together they form a unique fingerprint.
Sort by